These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3274860)

  • 1. B cell antibodies after planned transfusions.
    van den Berg-Loonen PM; Leunissen KM; Kootstra G; van Hooff JP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):743. PubMed ID: 3274860
    [No Abstract]   [Full Text] [Related]  

  • 2. [HLA and transfusions in 100 renal transplantations].
    Trovati A; Monari C; Renna E; Berloco P; Cucchiara G; Famulari A; Cortesini R
    Minerva Chir; 1980 May; 35(10):705-8. PubMed ID: 7005725
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibody response to histocompatibility antigens in hemodialysis patients subjected to planned whole-blood transfusions].
    Fagiolo U; Corsano A; Antonello A; Venturi-Pasini C; Dal Lago O; Indiveri F
    Minerva Chir; 1980 May; 35(10):701-4. PubMed ID: 7005724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved graft survival following donor-specific blood transfusions.
    Cochrum K; Hanes D; Potter D; Perkins H; Amend W; Vincenti F; Iwaki Y; Opelz G; Terasaki P; Levin B; Sampson D; Feduska N; Salvatierra O
    Transplant Proc; 1981 Sep; 13(3):1657-61. PubMed ID: 7029829
    [No Abstract]   [Full Text] [Related]  

  • 5. [The sensitized rate of preformed antibodies in the candidate of renal transplant recipient].
    Nishigaki F; Yoda K; Takahashi T; Takimoto K; Watanabe T; Shimokawa H; Hirano T; Kataoka Y; Yoshiki T
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):859-63. PubMed ID: 3074028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood transfusions as "transplantation pretreatment": incidence of immunization against unfractionated lymphocytes, T- and B-lymphocytes.
    Fehrman I; Opelz G
    Scand J Urol Nephrol Suppl; 1981; 64():93-9. PubMed ID: 6755690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood transfusions under cyclosporine coverage before renal transplantation in children.
    Niaudet P; Bouvattier C; Gouda H; Mattlinger B; Caillat-Zucman S; Gagnadoux MF; Broyer M; Jean G
    Transplant Proc; 1995 Apr; 27(2):1723-4. PubMed ID: 7725470
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the risk factors associated with donor specific blood transfusion.
    Vaidya S; Sommer BG; Pagel EA; Koegel M; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2268. PubMed ID: 3274505
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of anti-HLA antibody using small-dose single-donor blood transfusion.
    Ettenger R; Cho S; Marik J; von Lilien T; Fine RN
    Transplant Proc; 1987 Feb; 19(1 Pt 1):740-2. PubMed ID: 3274859
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation.
    Adorno D; Valeri M; Piazza A; Bonini S; Papola F; Casciani CU
    Transplant Proc; 1979 Jun; 11(2):1269-70. PubMed ID: 382505
    [No Abstract]   [Full Text] [Related]  

  • 14. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 15. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.
    Vaidya S
    Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anti-F(ab)2 gamma antibodies by buffy coat transfusions and their effect in kidney transplantation.
    Süsal C; Guo Z; Terness P; Padányi A; Petrányi G; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1893-4. PubMed ID: 2389476
    [No Abstract]   [Full Text] [Related]  

  • 19. Positive crossmatches due to autoantibodies in living-related transplantation.
    Myrberg SJ; Connors CM; Carpenter CB; Garovoy MR
    Transplant Proc; 1979 Dec; 11(4):1954-7. PubMed ID: 394440
    [No Abstract]   [Full Text] [Related]  

  • 20. Serological study of patients receiving prospective blood transfusions before kidney transplantation.
    Nebout T; Bracq C; Mannioni P; Fruchaud G; Abbou C
    Proc Eur Dial Transplant Assoc; 1980; 17():486-90. PubMed ID: 7017695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.